Boehringer Can Keep Many Docs On Barr Deal Away From FTC
A Washington federal judge ruled Thursday that many of the documents the Federal Trade Commission had sought from Boehringer Ingelheim Pharmaceuticals Inc. about its patent settlements with Barr Pharmaceuticals Inc. were...To view the full article, register now.
Already a subscriber? Click here to view full article